Starpharma Holdings Limited (SPHRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0540
-0.0018 (-3.23%)
At close: Dec 18, 2024
Starpharma Holdings Revenue
In the fiscal year ending June 30, 2024, Starpharma Holdings had annual revenue of 9.76M AUD with 124.64% growth. Starpharma Holdings had revenue of 1.73M in the half year ending June 30, 2024, a decrease of -44.48%.
Revenue
9.76M AUD
Revenue Growth
+124.64%
P/S Ratio
n/a
Revenue / Employee
243.90K AUD
Employees
40
Market Cap
26.05M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9.76M | 5.41M | 124.64% |
| Jun 30, 2023 | 4.34M | -819.00K | -15.87% |
| Jun 30, 2022 | 5.16M | 1.68M | 48.04% |
| Jun 30, 2021 | 3.49M | -3.63M | -50.99% |
| Jun 30, 2020 | 7.12M | 4.40M | 161.58% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Ryman Healthcare Limited | 458.44M |
| Elekta AB (publ) | 1.66B |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |